Background: Previous studies have shown the effect of a unique therapy with a non-invasive biomechanical foot worn device (AposTherapy) on Caucasian western population suffering from knee OA. The purpose of the current study to evaluate the effect of this therapy on the level of symptoms and gait patterns in a multi-ethnic Asian population suffering from knee OA. Methods: Fifty-eight patients with bilateral medial compartment knee OA participated in the study. All patients underwent a computerized gait test and completed two self-assessment questionnaires . The biomechanical device was calibrated to each patient and therapy commenced. Changes in gait patterns and self-assessment questionnaires were reassessed after 3 and 6 months of therapy. Results: A significant improvement was seen in all of the gait parameters following 6 months of therapy. Specifically, gait velocity increased by 15.9%, step length increased by 10.3%, stance phase decreased by 5.9% and single limb support phase increased by 2.7%. In addition, pain, stiffness and functional limitation significantly decreased by 68.3%, 66.7% and 75.6%, respectively. Conclusion: The multi-ethnic Asian population with medial compartment knee OA demonstrated improved gait patterns, reported alleviation in symptoms and improved function and quality of life following 6 months of therapy with a unique biomechanical device. Background: OA is the commonest arthritis, and is increasing in prevalence. NICE OA guidelines include IA corticosteroid injections as an adjunctive treatment. There are theoretical concerns that their use prior to joint replacement surgery may increase the risk of postoperative infection. The aim of this systematic review was to examine whether IA corticosteroid injection pre-arthroplasty increases the risk of post-operative infection. Methods: A systematic literature search was undertaken in MEDLINE, EMBASE, CINHAL, AMED, Cochrane library, and Web of Science databases using terms pertaining to corticosteroids, IA injection and joint replacement. Results were screened by title and abstract following the removal of duplicates. During the screening process exclusion and inclusion criteria were applied. Eligible studies were empirical human studies which included IA steroid injection prior to arthroplasty as an exposure and post-arthroplasty infection rates as an outcome. Those that satisfied the criteria underwent full-text review by 2 reviewers; study quality was assessed using Newcastle-Ottawa quality appraisal tools. Risk estimates from each study were compared, with pooled estimates (95% CI) of the risk of postoperative infection calculated using a random effects model. Heterogeneity was assessed visually with Forest plots and numerically with Cochran's Q test and I2 test. Results: 61 papers were identified. After abstract screening, 8 papers met the inclusion criteria. 4 additional studies were identified through citation searches. 6 studies pertained to hip replacement and 6 to knee replacement. 3 studies from each were appropriate for meta-analysis. Quality appraisal revealed that many studies lacked a control group (n ¼ 6), some had small sample sizes (n ¼ 36) and some did not specify type of infection (n ¼ 3). For hip replacement, the pooled odds ratio between IA steroid injection and post-operative infection was 1.72 (95% CI 0.54, 4.59), relative risk 1.61 (95% CI 0.94, 2.76) and percentage difference in infection rate between study and control groups 0.04 (95% CI -0.04, 0.11). For knee replacement, pooled odds ratio was 1.57 (95% CI 0.49, 5.03), relative risk 1.58 (95% CI 0.61, 4.08) and percentage difference in infection rate between study and control group was 0.026 (95% CI -0.059, 0.111). Conclusion: Post-operative infection rate does not appear to increase with prior IA steroid injection, although the methodological quality of studies was generally poor. Larger studies are required to be definitive, but at present, there is no evidence to support delaying arthroplasty after IA steroid injection. Disclosure statement: The authors have declared no conflicts of interest.
THE EFFECT OF A BIOMECHANICAL GAIT-TRAINING DEVICE ON GAIT PATTERNS OF OBESE KNEE OSTEOARTHRITIS PATIENTS
Omri Lubobvsky 1 , Amit Mor 2 , Ganit Segal 2 , Ronen Debi 1 , Yiftah Beer 3 and Avi Elbaz 2 1 Orthopedic Department, Barzilay Medical Center, Ashkelon, Israel, 2 Research group, AposTherapy, Herzliya, Israel, 3 Orthopedic Department, Assaf Harofeh Medical Center, Zerifin, Israel Background: Obesity is strongly linked to knee OA and is considered a risk factor for both incidence and progression. Obese patients with knee OA tend to walk slower, have shorter step length, cadence and single limb support (SLS). Most obese patients fail to comply with weight-reduction programmes to relief pain and improve function. Several biomechanical treatments for knee OA have emerged with the goal of reducing pain, improving function and halting disease progression. These treatments aim to unload the diseased articular surface by using wedged insoles, foot orthoses, unique shoes or valgus braces. The aim of this study was to examine the effect of a biomechanical, home-based, gait training device on gait patterns of obese patients suffering from knee OA. Methods: This was a retrospective analysis of 105 (32 males and 73 females) obese patients (BMI > 30 kg/m 2 ) with knee OA. All patients underwent a computerized gait test to characterize spatio-temporal parameters and were asked to complete The Western Ontario and McMaster Osteoarthritis Index (WOMAC) questionnaire and SF-36 Health Survey. Patients were fitted with the biomechanical gait training device and received home-based exercise programme. Patients returned to the clinic for additional assessments of gait patterns and clinical symptoms following 3 and 12 months of therapy. One-way repeated measure ANOVA was applied to determine significant changes over time, P-value was set to P < 0.05. Results: Significant improvements in gait pattern were found in all parameters after 3 months of therapy with an additional improvement following 12 months of therapy. Gait velocity increased by 11.8% following 3 months of therapy and further improved by an additional 4.3%. SLS of the more symptomatic knee increase by 2.5% following 3 months of therapy and further improved by an additional 1.1%. A significant reduction in pain, stiffness and functional limitation was seen after 3 months of therapy with an additional improvement following 12 months of therapy. Pain decreased by 34.7% following 3 months of therapy and further decreased by an additional 11.0%. Functional limitation decreased by 35.0% following 3 months of therapy and further decreased by an additional 9.7%. Both Physical Scale and Mental Scale of the SF-36 increased significantly following 3 months of therapy and further increased following 12 months of therapy. Conclusion: Obese patients with knee OA complied with a homebased exercise programme using a biomechanical gait training device. Patients demonstrated a significant improvement in gait patterns and clinical symptoms mainly after 3 months of therapy with an additional improvement after 12 months of therapy. This therapy may help obese patient with knee OA to become active and persist with an exercise programme that will lead them to relieved pain and improved function. Disclosure statement: A.M. is a shareholder in Apos Medical and Sports Technologies. G.S. is an employee of Apos. R.D. is a shareholder in Apos Medical and Sports Technologies. A.E. is a shareholder in Apos Medical and Sports Technologies. All other authors have declared no conflicts of interest.
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